HEADER TRANSFERASE 27-JAN-07 2E9V TITLE STRUCTURE OF H-CHK1 COMPLEXED WITH A859017 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 2-270; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.PARK REVDAT 4 13-MAR-24 2E9V 1 REMARK REVDAT 3 28-AUG-19 2E9V 1 REMARK REVDAT 2 24-FEB-09 2E9V 1 VERSN REVDAT 1 29-JAN-08 2E9V 0 JRNL AUTH Y.TONG,A.CLAIBORNE,K.D.STEWART,C.PARK,P.KOVAR,Z.CHEN, JRNL AUTH 2 R.B.CREDO,S.L.GWALTNEY,H.ZHANG,S.H.ROSENBERG,H.L.SHAM, JRNL AUTH 3 T.J.SOWIN,N.H.LIN JRNL TITL STRUCTURE-BASED DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION JRNL TITL 2 OF POTENT SELECTIVE MACROCYCLIC CHK1 INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 582152.860 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 72.3 REMARK 3 NUMBER OF REFLECTIONS : 27793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.272 REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.333 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2783 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 38402 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 36.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1255 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 124 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4352 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 430 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.00000 REMARK 3 B22 (A**2) : -11.99000 REMARK 3 B33 (A**2) : 10.99000 REMARK 3 B12 (A**2) : -5.07000 REMARK 3 B13 (A**2) : 2.24000 REMARK 3 B23 (A**2) : -8.95000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.24 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.750 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.300 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 0.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.270 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.45 REMARK 3 BSOL : 90.73 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : A85.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : A85.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2E9V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000026407. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-04 REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32755 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.3 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 36.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.24500 REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, ISOPROPANOL, HEPES, PH 7.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 880 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 3 84.38 -160.09 REMARK 500 PHE A 5 -36.59 160.12 REMARK 500 GLU A 7 10.95 145.35 REMARK 500 TYR A 20 -5.97 174.89 REMARK 500 GLU A 22 -177.42 169.02 REMARK 500 ARG A 29 -0.38 -57.02 REMARK 500 VAL A 30 -76.71 -141.92 REMARK 500 MET A 42 29.28 -66.91 REMARK 500 LYS A 43 137.39 -33.72 REMARK 500 ARG A 44 -153.99 55.95 REMARK 500 VAL A 46 -48.50 -178.31 REMARK 500 ASP A 47 45.14 -107.66 REMARK 500 CYS A 48 -55.70 -165.89 REMARK 500 ASN A 51 -65.91 -128.13 REMARK 500 ASN A 63 90.05 -175.42 REMARK 500 GLU A 76 -79.35 -39.38 REMARK 500 SER A 88 1.68 -59.27 REMARK 500 PRO A 98 123.54 -38.68 REMARK 500 ILE A 100 -43.47 -138.55 REMARK 500 ARG A 129 14.92 59.71 REMARK 500 ASP A 130 48.82 -162.97 REMARK 500 ASP A 148 98.09 55.26 REMARK 500 TYR A 157 160.25 166.44 REMARK 500 ASN A 158 13.07 53.73 REMARK 500 ASN A 159 31.04 70.98 REMARK 500 ASN A 165 -29.45 -155.97 REMARK 500 LEU A 171 -68.51 -25.69 REMARK 500 VAL B 3 64.12 -161.07 REMARK 500 PHE B 5 -29.59 154.44 REMARK 500 GLU B 7 13.02 145.06 REMARK 500 ALA B 19 54.33 -91.51 REMARK 500 TYR B 20 -38.32 -163.39 REMARK 500 GLU B 22 -179.67 167.01 REMARK 500 ARG B 29 -7.61 -49.02 REMARK 500 VAL B 30 -69.89 -139.56 REMARK 500 GLU B 32 -0.23 75.33 REMARK 500 MET B 42 44.90 -83.06 REMARK 500 ARG B 44 -158.39 52.40 REMARK 500 ALA B 45 89.52 -158.31 REMARK 500 VAL B 46 -50.95 179.89 REMARK 500 ASP B 47 40.26 -103.05 REMARK 500 CYS B 48 -50.48 -159.19 REMARK 500 ASN B 63 81.98 -170.74 REMARK 500 GLU B 76 -82.42 -13.64 REMARK 500 ASN B 78 13.07 -144.84 REMARK 500 PRO B 98 125.32 -39.94 REMARK 500 ILE B 100 -51.76 -132.93 REMARK 500 ASP B 130 54.22 -162.50 REMARK 500 ASP B 148 96.20 63.09 REMARK 500 ASN B 165 -11.12 -155.89 REMARK 500 REMARK 500 THIS ENTRY HAS 52 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1056 DISTANCE = 6.39 ANGSTROMS REMARK 525 HOH A1112 DISTANCE = 6.91 ANGSTROMS REMARK 525 HOH A1134 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH B2090 DISTANCE = 5.90 ANGSTROMS REMARK 525 HOH B2138 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH B2193 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH B2208 DISTANCE = 6.31 ANGSTROMS REMARK 525 HOH B2225 DISTANCE = 6.46 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 85A A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 85A B 2001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AYP RELATED DB: PDB REMARK 900 RELATED ID: 2FGA RELATED DB: PDB REMARK 900 RELATED ID: 2GHG RELATED DB: PDB REMARK 900 RELATED ID: 2E9N RELATED DB: PDB REMARK 900 RELATED ID: 2E9O RELATED DB: PDB REMARK 900 RELATED ID: 2E9P RELATED DB: PDB REMARK 900 RELATED ID: 2E9U RELATED DB: PDB DBREF 2E9V A 2 269 UNP O14757 CHK1_HUMAN 2 269 DBREF 2E9V B 2 269 UNP O14757 CHK1_HUMAN 2 269 SEQRES 1 A 268 ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN THR SEQRES 2 A 268 LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA VAL SEQRES 3 A 268 ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE VAL SEQRES 4 A 268 ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE LYS SEQRES 5 A 268 LYS GLU ILE CYS ILE ASN LYS MET LEU ASN HIS GLU ASN SEQRES 6 A 268 VAL VAL LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN ILE SEQRES 7 A 268 GLN TYR LEU PHE LEU GLU TYR CYS SER GLY GLY GLU LEU SEQRES 8 A 268 PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU PRO SEQRES 9 A 268 ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY VAL SEQRES 10 A 268 VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP ILE SEQRES 11 A 268 LYS PRO GLU ASN LEU LEU LEU ASP GLU ARG ASP ASN LEU SEQRES 12 A 268 LYS ILE SER ASP PHE GLY LEU ALA THR VAL PHE ARG TYR SEQRES 13 A 268 ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY THR SEQRES 14 A 268 LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG GLU SEQRES 15 A 268 PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY ILE SEQRES 16 A 268 VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP ASP SEQRES 17 A 268 GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP LYS SEQRES 18 A 268 GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE ASP SEQRES 19 A 268 SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL GLU SEQRES 20 A 268 ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS LYS SEQRES 21 A 268 ASP ARG TRP TYR ASN LYS PRO LEU SEQRES 1 B 268 ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN THR SEQRES 2 B 268 LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA VAL SEQRES 3 B 268 ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE VAL SEQRES 4 B 268 ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE LYS SEQRES 5 B 268 LYS GLU ILE CYS ILE ASN LYS MET LEU ASN HIS GLU ASN SEQRES 6 B 268 VAL VAL LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN ILE SEQRES 7 B 268 GLN TYR LEU PHE LEU GLU TYR CYS SER GLY GLY GLU LEU SEQRES 8 B 268 PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU PRO SEQRES 9 B 268 ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY VAL SEQRES 10 B 268 VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP ILE SEQRES 11 B 268 LYS PRO GLU ASN LEU LEU LEU ASP GLU ARG ASP ASN LEU SEQRES 12 B 268 LYS ILE SER ASP PHE GLY LEU ALA THR VAL PHE ARG TYR SEQRES 13 B 268 ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY THR SEQRES 14 B 268 LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG GLU SEQRES 15 B 268 PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY ILE SEQRES 16 B 268 VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP ASP SEQRES 17 B 268 GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP LYS SEQRES 18 B 268 GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE ASP SEQRES 19 B 268 SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL GLU SEQRES 20 B 268 ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS LYS SEQRES 21 B 268 ASP ARG TRP TYR ASN LYS PRO LEU HET 85A A1001 34 HET 85A B2001 34 HETNAM 85A 18-CHLORO-2-OXO-17-[(PYRIDIN-4-YLMETHYL)AMINO]-2,3,11, HETNAM 2 85A 12,13,14-HEXAHYDRO-1H,10H-4,8-(AZENO)-9,15,1,3,6- HETNAM 3 85A BENZODIOXATRIAZACYCLOHEPTADECINE-7-CARBONITRILE HETSYN 85A 7-CHLORO-3-OXO-8-[(PYRIDIN-4-YLMETHYL)-AMINO]-11,17- HETSYN 2 85A DIOXA-2,4,20,22-TETRAAZA-TRICYCLO[16.3.1.0*5, HETSYN 3 85A 10*]DOCOSA-1(21),5(10)6,8,18(22),19-HEXAENE-19- HETSYN 4 85A CARBONITRILE FORMUL 3 85A 2(C23 H22 CL N7 O3) FORMUL 5 HOH *430(H2 O) HELIX 1 1 ASN A 51 LEU A 62 1 12 HELIX 2 2 PHE A 93 ILE A 96 5 4 HELIX 3 3 PRO A 103 ILE A 124 1 22 HELIX 4 4 THR A 170 ALA A 175 5 6 HELIX 5 5 PRO A 176 ARG A 181 1 6 HELIX 6 6 HIS A 185 GLY A 204 1 20 HELIX 7 7 CYS A 215 GLU A 223 1 9 HELIX 8 8 PRO A 230 ILE A 234 5 5 HELIX 9 9 ASP A 235 LEU A 246 1 12 HELIX 10 10 THR A 255 LYS A 260 1 6 HELIX 11 11 ASN B 51 LEU B 62 1 12 HELIX 12 12 PHE B 93 ILE B 96 5 4 HELIX 13 13 PRO B 103 ILE B 124 1 22 HELIX 14 14 ALA B 175 LYS B 180 5 6 HELIX 15 15 HIS B 185 GLY B 204 1 20 HELIX 16 16 CYS B 215 LYS B 222 1 8 HELIX 17 17 PRO B 230 ILE B 234 5 5 HELIX 18 18 ASP B 235 LEU B 246 1 12 HELIX 19 19 THR B 255 LYS B 260 1 6 SHEET 1 A 5 TRP A 9 THR A 14 0 SHEET 2 A 5 GLU A 22 ASN A 28 -1 O LEU A 25 N GLN A 13 SHEET 3 A 5 ALA A 34 ASP A 41 -1 O VAL A 35 N ALA A 26 SHEET 4 A 5 ILE A 79 LEU A 84 -1 O LEU A 84 N ALA A 36 SHEET 5 A 5 PHE A 70 ARG A 74 -1 N TYR A 71 O PHE A 83 SHEET 1 B 3 GLY A 90 GLU A 91 0 SHEET 2 B 3 LEU A 136 LEU A 138 -1 O LEU A 138 N GLY A 90 SHEET 3 B 3 LEU A 144 ILE A 146 -1 O LYS A 145 N LEU A 137 SHEET 1 C 2 ILE A 126 THR A 127 0 SHEET 2 C 2 THR A 153 VAL A 154 -1 O THR A 153 N THR A 127 SHEET 1 D 2 ARG A 156 TYR A 157 0 SHEET 2 D 2 ARG A 160 GLU A 161 -1 O ARG A 160 N TYR A 157 SHEET 1 E 5 TRP B 9 THR B 14 0 SHEET 2 E 5 GLY B 21 ASN B 28 -1 O LEU B 25 N GLN B 13 SHEET 3 E 5 ALA B 34 ASP B 41 -1 O VAL B 35 N ALA B 26 SHEET 4 E 5 ILE B 79 LEU B 84 -1 O LEU B 84 N ALA B 36 SHEET 5 E 5 PHE B 70 ARG B 74 -1 N GLY B 72 O PHE B 83 SHEET 1 F 3 GLY B 90 GLU B 91 0 SHEET 2 F 3 LEU B 136 LEU B 138 -1 O LEU B 138 N GLY B 90 SHEET 3 F 3 LEU B 144 ILE B 146 -1 O LYS B 145 N LEU B 137 SHEET 1 G 2 ILE B 126 THR B 127 0 SHEET 2 G 2 THR B 153 VAL B 154 -1 O THR B 153 N THR B 127 SHEET 1 H 2 ARG B 156 TYR B 157 0 SHEET 2 H 2 ARG B 160 GLU B 161 -1 O ARG B 160 N TYR B 157 CISPEP 1 ASN A 229 PRO A 230 0 0.31 CISPEP 2 ASN B 229 PRO B 230 0 -0.08 SITE 1 AC1 14 LEU A 15 VAL A 23 ALA A 36 LYS A 38 SITE 2 AC1 14 VAL A 68 LEU A 84 GLU A 85 TYR A 86 SITE 3 AC1 14 CYS A 87 GLU A 91 LEU A 137 ASP A 148 SITE 4 AC1 14 HOH A1006 HOH A1171 SITE 1 AC2 14 LEU B 15 VAL B 23 ALA B 36 LYS B 38 SITE 2 AC2 14 GLU B 55 VAL B 68 LEU B 84 GLU B 85 SITE 3 AC2 14 TYR B 86 CYS B 87 GLU B 91 LEU B 137 SITE 4 AC2 14 ASP B 148 HOH B2061 CRYST1 45.883 56.783 64.595 92.83 104.39 113.86 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021795 0.009640 0.007329 0.00000 SCALE2 0.000000 0.019257 0.003307 0.00000 SCALE3 0.000000 0.000000 0.016217 0.00000